NL-OMON44876
Completed
Not Applicable
The value of iron treatment for postoperative obstetric patients with anemia: a randomized double blind controlled trial - VITAPOP
Medisch Universitair Ziekenhuis Maastricht0 sites180 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Medisch Universitair Ziekenhuis Maastricht
- Enrollment
- 180
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion Criteria;The patient has undergone a primary caesarean section;The postoperative hemoglobin is between 5\-7 mmol / L
Exclusion Criteria
- •Exclusion Criteria;• Malignancy during pregnancy or during the first six weeks postpartum
- •HELLP syndrome
- •Pre\-eclampsia
- •Infections
- •Bloodtransfusions during pregnancy or peri\-or postoperative
- •Hematologic disorder (hemoglobinopathy; hemochromatosis)
- •Erythropoiesis\-stimulating agents \< 3months ago
- •Myelosuppressive therapy in history
- •Hepatitis
- •Alcohol abuses
Outcomes
Primary Outcomes
Not specified
Similar Trials
Terminated
Phase 4
The Use of Iron Therapy for Patients With Anemia After Caesarean SectionPostoperative AnaemiaNCT01975272Maastricht University Medical Center27
Active, not recruiting
Phase 1
A study of whether giving iron into the veins may be helpful for patients with broken hips.Anaemia following hip fractureTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2011-003233-34-GBniversity of Nottingham80
Active, not recruiting
Phase 1
Clinical trial to demonstrate safety and efficacy of an intravenous (i.v.) administration of Feramyl compared to i.v. Ferinject and to iron tablets in patients with iron deficiency diganosis before a planned operation who develop anaemia before, during or after surgerypre-operative iron deficiency in patients with planned elective surgery and pre-/post-operative iron deficiencyMedDRA version: 20.0Level: LLTClassification code 10022974Term: Iron deficiency anemiaSystem Organ Class: 100000004851Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2017-003439-12-ATFraunhofer Gesellschaft für sein Institut für Translationale Medizin und Pharmakologie (ITMP)407
Active, not recruiting
Phase 1
Clinical trial to demonstrate safety and efficacy of an intravenous (i.v.) administration of Feramyl compared to i.v. Ferinject and to iron tablets in patients with iron deficiency anaemia diagnosis before or after a planned surgerypre-operative iron deficiency in patients with planned elective surgery and pre-/post-operative iron deficiency anamiaMedDRA version: 20.0Level: LLTClassification code 10022974Term: Iron deficiency anemiaSystem Organ Class: 100000004851Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2017-003439-12-DEFraunhofer Gesellschaft for its Institute Fraunhofer für Translationale Medizin und Pharmakologie (ITMP)407
Unknown
Phase 4
Intraoperative IV Iron on Postoperative Red Blood Cell RecoveryOsteoarthritis, HipNCT04035902Konkuk University Medical Center46